Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB1901451	LCZ696片	sacubitril;valsartan	Tablet	Chemical Drugs(2.4)	Supplementary Application	2019-12-09	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2019-12-07	view
JYHB1901450	LCZ696片	sacubitril;valsartan	Tablet	Chemical Drugs(2.4)	Supplementary Application	2019-12-09	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2019-12-07	view
JYHB1901452	LCZ696片	sacubitril;valsartan	Tablet	Chemical Drugs(2.4)	Supplementary Application	2019-12-09	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2019-12-07	view
JXHL1900042	LEE011	ribociclib succinate	Active ingredient	Chemical Drugs(2.4)	Import Drug Application	2019-02-25	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2019-02-23	view
JXHL1800171	PKC412软胶囊	midostaurin	Soft capsules	Chemical Drugs(2.4)	Import Drug Application	2018-12-05	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-12-04	view
JXSL1800042	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-29	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-27	view
JXSL1800040	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-29	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-27	view
JXSL1800041	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-26	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-25	view
JXSL1800043	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-26	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-25	view
JTH1800361	富马酸阿利吉仑	aliskiren hemifumarate	Active ingredient	Chemical Drugs	Disposable Import Drug Application	2018-10-16	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-11-06	view
JXHL1800123	MAK683	MAK683	Active ingredient	Chemical Drugs(1)	Import Drug Application	2018-09-25	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-10-29	view
JXHL1800125	MAK683	MAK683	Active ingredient	Chemical Drugs(1)	Import Drug Application	2018-09-25	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-10-29	view
JXHL1800124	MAK683	MAK683	Active ingredient	Chemical Drugs(1)	Import Drug Application	2018-09-25	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-10-29	view
JXSL1800007	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-02-22	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-08-27	view
JXSL1800006	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-02-22	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-08-27	view
JXHL1700204	MAK683	MAK683	Active ingredient	Chemical Drugs(1)	Import Drug Application	2017-11-15	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-04-28	view
JXHL1700206	MAK683	MAK683	Active ingredient	Chemical Drugs(1)	Import Drug Application	2017-11-15	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-04-28	view
JXHL1700205	MAK683	MAK683	Active ingredient	Chemical Drugs(1)	Import Drug Application	2017-11-15	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-04-28	view
JXHL1700178	LCZ696片	sacubitril;valsartan	Tablet	Chemical Drugs(2.4)	Import Drug Application	2017-09-26	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-06-08	view
JXHL1700177	LCZ696片	sacubitril;valsartan	Tablet	Chemical Drugs(2.4)	Import Drug Application	2017-09-26	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-06-08	view